Ark Solutions Inc
203690
Company Profile
Business description
Ark Solutions Inc operates in the Life and health sector. It conducts business through OEM manufacturing of wet tissues. The wet tissue manufacturing sector manufactures baby wet tissues, general wet tissues, bidet wet tissues, and others. The group researches and develops pharmaceuticals, cosmetics, and health-functional foods based on various biomaterials, and possesses ExoPlant Technology. Its business areas include Bio Business and Stem Cell cosmetics business.
Contact
218 Bongeunsa-ro
Gangnam-gu, 8th Floor
Seoul
KORT: +82 25452818
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
55
Stocks News & Analysis
stocks
Chart of the Week: Opportunities with wide-moat retailers
Consumer defensive names look undervalued.
stocks
New ASX share added to our best ideas
Earnings outlook is strong and the shares trade at a discount to our fair value.
stocks
Fair value downgraded for ASX heavyweight
Our capital allocation rating was also lowered due to balance sheet weakness.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,240.30 | 42.60 | 0.46% |
| CAC 40 | 8,075.76 | 108.81 | 1.37% |
| DAX 40 | 24,449.08 | 335.46 | 1.39% |
| Dow JONES (US) | 46,441.10 | 43.21 | 0.09% |
| FTSE 100 | 9,453.25 | 6.82 | 0.07% |
| HKSE | 27,287.12 | 431.56 | 1.61% |
| NASDAQ | 22,755.16 | 95.15 | 0.42% |
| Nikkei 225 | 44,936.73 | 385.88 | 0.87% |
| NZX 50 Index | 13,451.76 | 17.77 | 0.13% |
| S&P 500 | 6,711.20 | 22.74 | 0.34% |
| S&P/ASX 200 | 8,945.90 | 40.10 | 0.45% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |